IBRN · iShares Neuroscience and Healthcare ETF
iShares Trust
$31.51
-1.02%
At close · Oct 21
Net assets $5,485,479
Holdings78
1 month
-7.62%
Year to date
-2.50%
52-week range
$27.70–$43.01
30-session avg volume
1,782
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000076483
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings56.23%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC95.51%
STIV14.75%
Country allocation
US85.16%
CA5.47%
IE5.01%
NL3.86%
KR2.42%
SE2.36%
DK1.84%
Other8.52%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | $802,948 | 14.64% |
| Dianthus Therapeutics Inc | DNTH | $292,854 | 5.34% |
| Xenon Pharmaceuticals Inc | XENE | $267,225 | 4.87% |
| Praxis Precision Medicines Inc | PRAX | $267,196 | 4.87% |
| ACADIA PHARMACEUTICALS INC. | ACAD | $257,381 | 4.69% |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | $255,304 | 4.65% |
| ALKERMES PUBLIC LIMITED COMPANY | ALKS | $252,445 | 4.60% |
| Scholar Rock Holding Corp | SRRK | $235,482 | 4.29% |
| BIOGEN INC. | BIIB | $229,131 | 4.18% |
| NEUROCRINE BIOSCIENCES, INC. | NBIX | $224,346 | 4.09% |
| argenx SE | ARGX | $211,747 | 3.86% |
| PTC THERAPEUTICS, INC. | PTCT | $211,443 | 3.85% |
| AXSOME THERAPEUTICS, INC. | AXSM | $206,873 | 3.77% |
| Denali Therapeutics Inc | DNLI | $201,425 | 3.67% |
| Dyne Therapeutics, Inc | DYN | $195,498 | 3.56% |
| Edgewise Therapeutics Inc | EWTX | $177,354 | 3.23% |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | $142,905 | 2.61% |
| AxoGen, Inc. | AXGN | $128,361 | 2.34% |
| SK Biopharmaceuticals Co Ltd | Y806MN108 | $126,095 | 2.30% |
| H. LUNDBECK A/S | $100,792 | 1.84% | |
| Biohaven Ltd | BHVN | $99,590 | 1.82% |
| SAREPTA THERAPEUTICS, INC. | SRPT | $88,476 | 1.61% |
| BioArctic AB | $85,563 | 1.56% | |
| Taysha Gene Therapies Inc | TSHA | $82,034 | 1.50% |
| Neuren Pharmaceuticals Ltd | $81,113 | 1.48% | |
| Idorsia Ltd | $78,965 | 1.44% | |
| Rapport Therapeutics Inc | RAPP | $68,560 | 1.25% |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | IART | $65,185 | 1.19% |
| Alto Neuroscience Inc | ANRO | $49,971 | 0.91% |
| LB Pharmaceuticals Inc | LBRX | $48,938 | 0.89% |
| Dynavox Group AB | $43,886 | 0.80% | |
| Annexon Inc | ANNX | $42,696 | 0.78% |
| Medincell SA | $41,256 | 0.75% | |
| Solid Biosciences Inc | SLDB | $37,068 | 0.68% |
| Bright Minds Biosciences Inc | DRUG | $32,601 | 0.59% |
| Relmada Therapeutics Inc | RLMD | $28,759 | 0.52% |
| Design Therapeutics Inc | DSGN | $26,979 | 0.49% |
| Regenxbio Inc | RGNX | $26,638 | 0.49% |
| Oncolys Biopharma Inc | J61461109 | $26,307 | 0.48% |
| Brainsway Ltd | BWAY | $26,257 | 0.48% |
| Ceribell Inc | CBLL | $25,597 | 0.47% |
| NEUROGENE INC. | NGNE | $24,339 | 0.44% |
| Clearpoint Neuro Inc | CLPT | $23,486 | 0.43% |
| Benitec Biopharma Inc | BNTC | $23,198 | 0.42% |
| Prothena Corporation PLC | PRTA | $22,403 | 0.41% |
| OVID THERAPEUTICS INC. | OVID | $21,705 | 0.40% |
| MicroPort NeuroScientific Corp | $21,657 | 0.39% | |
| Neuropace Inc | NPCE | $19,889 | 0.36% |
| SanBio Company Limited | $19,555 | 0.36% | |
| Zylox-Tonbridge Medical Technology Co Ltd | $19,417 | 0.35% |
Showing the top 50 of 78 holdings. Create a free account to see every holding and download the CSV.